The use of CRISPR interference (CRISPRi) to repress the expression of mutant with relative preservation of wild-type huntingtin may represent a potential therapeutic strategy to delay disease progression in a mouse model of Huntington’s disease. The gene discussed is HTT; the disease is Huntington disease.